Notably, chronic systemic inflammation caused by abnormal levels of CD4+T cells and NK cells in PsA patients promotes the occurrence and development of hepatic steatosis, especially NAFLD, and significantly increases the risk of advanced liver disease. The gene discussed is CD4; the disease is Hepatic steatosis.